Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Other Working Capital history
Currency unavailable · from the cash flow
No Other Working Capital data reported for this period type.
Other Working Capital vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $21.39M USD | — | — | — |
| LTM Mar 2026 | $9.21M USD | +109.8% | — | — | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | $8.69M USD | -1032.5% | +70.8% | — |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | $4.68M USD | -124.6% | -55.3% | — |
| LTM Mar 2026 | $4.33M USD | +147.2% | — | 2.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | $1.11M USD | -135.8% | -4.7% | 5.5% |
| LTM Mar 2026 | $495.64K USD | +217.7% | — | — | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -7.4% | -4.7% | 3.8% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.